BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1377406)

  • 41. Density gradient separation of hematopoietic stem cells in autologous bone marrow transplantation.
    Iacone A; Quaglietta AM; D'Antonio D; Accorsi P; Dragani A; Angrilli F; Berardi A; Angelini A; Di Bartolomeo P; Di Bartolomeo G
    Haematologica; 1991 Mar; 76 Suppl 1():18-21. PubMed ID: 1677910
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Persistent decrease in proliferative potential of marrow CD34(+)cells exposed to early-acting growth factors after autologous bone marrow transplantation.
    Domenech J; Cartron G; Clement N; Estienne MH; Herault O; Truglio D; Benboubker L; Roingeard F; Desbois I; Colombat P; Binet C
    Bone Marrow Transplant; 2002 Apr; 29(7):557-62. PubMed ID: 11979303
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factors affecting volume reduction and red blood cell depletion of bone marrow on the COBE Spectra cell separator before haematopoietic stem cell transplantation.
    Guttridge MG; Sidders C; Booth-Davey E; Pamphilon D; Watt SM
    Bone Marrow Transplant; 2006 Aug; 38(3):175-81. PubMed ID: 16770313
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A two-phase approach to B lymphocyte purging of autologous bone marrow grafts for patients with malignant lymphoma contaminated bone marrow.
    Farley TJ; Preti RA; Ahmed T; Ciavarella D
    Prog Clin Biol Res; 1994; 389():105-9. PubMed ID: 7535430
    [No Abstract]   [Full Text] [Related]  

  • 45. Large-scale preparation of highly purified, frozen/thawed CD34+, HLA-DR- hematopoietic progenitor cells by sequential immunoadsorption (CEPRATE SC) and fluorescence-activated cell sorting: implications for gene transduction and/or transplantation.
    Körbling M; Drach J; Champlin RE; Engel H; Huynh L; Kleine HD; Berenson R; Deisseroth AB; Andreeff M
    Bone Marrow Transplant; 1994 May; 13(5):649-54. PubMed ID: 7519938
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rationale for large scale bone marrow hemopoietic stem cell manipulation.
    Menichella G; Pierelli L; Vittori M; Paoloni A; Foddai ML; Serafini R; Iacone A; Mango G
    Haematologica; 1991 Mar; 76 Suppl 1():3-6. PubMed ID: 1677911
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Autologous transplantation of hematopoietic precursor cells following CD34 selection].
    Tichelli A; Gratwohl A; Bargetzi M; Nissen C; Wernli M; Herrmann R; Orth B; Signer E; Speck B
    Schweiz Med Wochenschr; 1996 Feb; 126(6):201-6. PubMed ID: 8720723
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Isolation and characterization of CD34+ hematopoietic stem cells from human peripheral blood by high-gradient magnetic cell sorting.
    Kato K; Radbruch A
    Cytometry; 1993; 14(4):384-92. PubMed ID: 7685679
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of depletion of class II bright cells on the immunogenicity and stem cell content of human vertebral body bone marrow.
    Kenyon NS; Xu XM; Garcia-Serra A; Ricordi C
    Transplant Proc; 1995 Dec; 27(6):3419. PubMed ID: 8540031
    [No Abstract]   [Full Text] [Related]  

  • 50. Engraftment of CD34+ peripheral blood progenitor cells into multiple myeloma patients following total body irradiation.
    Pico JL; Bourhis JH; Bennaceur AL; Beaujean F; Bayle C; Ibrahim A; Girinski T; Hayat M; Dighiero G; Tchernia G
    Nouv Rev Fr Hematol (1978); 1995; 37(6):381-3. PubMed ID: 8907636
    [No Abstract]   [Full Text] [Related]  

  • 51. Peripheral-blood stem-cell transplantation.
    Med Lett Drugs Ther; 1995 Aug; 37(955):71-2. PubMed ID: 7543181
    [No Abstract]   [Full Text] [Related]  

  • 52. Characterization of chemotherapy mobilized peripheral blood progenitor cells for use in autologous stem cell transplantation.
    Bender JG; Williams SF; Myers S; Nottleman D; Lee WJ; Unverzagt KL; Walker D; To LB; Van Epps DE
    Bone Marrow Transplant; 1992 Sep; 10(3):281-5. PubMed ID: 1384900
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A randomized controlled clinical trial to determine the optimum duration of G-CSF priming prior to BM stem cell harvesting.
    Lowenthal RM; Ragg SJ; Anderson J; Nicholson L; Harrup RA; Tuck D
    Cytotherapy; 2007; 9(2):158-64. PubMed ID: 17453967
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Autografting with peripheral blood stem cells mobilized by sequential interleukin-3/granulocyte-macrophage colony-stimulating factor following high-dose chemotherapy in non-Hodgkin's lymphoma.
    Haas R; Ehrhardt R; Witt B; Goldschmidt H; Hohaus S; Pförsich M; Ehrlich H; Färber L; Hunstein W
    Bone Marrow Transplant; 1993 Dec; 12(6):643-9. PubMed ID: 7511017
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants.
    Eppich HM; Foxall R; Gaynor K; Dombkowski D; Miura N; Cheng T; Silva-Arrieta S; Evans RH; Mangano JA; Preffer FI; Scadden DT
    Nat Biotechnol; 2000 Aug; 18(8):882-7. PubMed ID: 10932160
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rapid and safe automated processing of bone marrow grafts without using density gradient cryopreservation and transplantation.
    Deméocq F; Kanold J; Bezou MJ; Travade P; Chassagne J; Berger M
    Prog Clin Biol Res; 1994; 389():675-84. PubMed ID: 7700935
    [No Abstract]   [Full Text] [Related]  

  • 57. Methodologies to estimate circulating hematopoietic progenitors for autologous transplantation in cancer patients.
    Ravagnani F; Siena S; Bregni M; Brando B; Belli N; Lansdorp PM; Notti P; Pellegris G; Gianni AM
    Haematologica; 1991 Mar; 76 Suppl 1():46-9. PubMed ID: 1713874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Autologous bone marrow support and bone disease in metastatic breast cancer.
    Nabholtz JM; al-Tweigeri T; Jacquelin N; Venner PM
    Can J Oncol; 1995 Jul; 5(2):369-75. PubMed ID: 8853509
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The presence of an autologous marrow stromal cell layer increases glucocerebrosidase gene transduction of long-term culture initiating cells (LTCICs) from the bone marrow of a patient with Gaucher disease.
    Wells S; Malik P; Pensiero M; Kohn DB; Nolta JA
    Gene Ther; 1995 Oct; 2(8):512-20. PubMed ID: 8593601
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
    Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
    Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.